Seroprevalence of Severe Fever with Thrombocytopenia Syndrome in Southeastern Korea, 2015.
10.3346/jkms.2017.32.1.29
- Author:
Kye Hyung KIM
1
;
Mee Kyung KO
;
Namhee KIM
;
Hyung Hoi KIM
;
Jongyoun YI
Author Information
1. Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
- Publication Type:Original Article
- Keywords:
Bunyaviridae Infections;
Zoonosis;
Seroepidemiologic Studies;
Communicable Diseases, Emerging
- MeSH:
Antibodies;
Bunyaviridae Infections;
Communicable Diseases, Emerging;
Cross-Sectional Studies;
Diarrhea;
Enzyme-Linked Immunosorbent Assay;
Fever*;
Humans;
Immunoglobulin G;
Immunoglobulin M;
Korea*;
Male;
Polymerase Chain Reaction;
Reverse Transcription;
Rural Population;
Seroepidemiologic Studies*;
Tertiary Care Centers;
Thrombocytopenia*;
Tick-Borne Diseases
- From:Journal of Korean Medical Science
2017;32(1):29-32
- CountryRepublic of Korea
- Language:English
-
Abstract:
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease characterized by fever, thrombocytopenia and diarrhea. SFTS was firstly reported in Korea in 2013 but its seroprevalence in the country has yet to be investigated. Here, we investigate the seroprevalence of SFTS in a Korean population. A cross-sectional study was conducted on patients who had their sera tested for various reasons at a tertiary university hospital on particular days in May 2015. This study was conducted in a tertiary hospital in southeastern Korea. Total antibodies including immunoglobulin G (IgG) and immunoglobulin M (IgM), specific to SFTS virus (SFTSV) in serum samples were detected by a double-antigen sandwich enzyme-linked immunosorbent assay (ELISA). A total of 1,069 serum samples were tested. Median age was 59 years (range 12–96 years), and 51.5% were male. Overall, 22 patients (2.1%) were tested positive for anti-SFTSV antibodies. The SFTS seroprevalence increased significantly with age (P = 0.034). The seropositive rate of rural area was higher than that of urban area (7.7% vs. 1.9%, P = 0.040). Seropositive rates were not significantly different among underlying diseases. None of the antibody-positive patients showed typical symptoms or laboratory findings of SFTS at the time of sample collection. Results of real-time reverse transcription polymerase chain reaction (RT-PCR) were negative for all the seropositive patients. Our study shows 2.1% SFTS seroprevalence among the patients visiting a tertiary hospital in Korea. Seroprevalence is higher in older and rural population.
